New eye drops promise quick redness relief in minutes
NCT ID NCT07578363
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an investigational eye drop (FID 123472) to see how well and how safely it reduces eye redness from minor irritations in adults. About 178 participants will receive either the active drop or a placebo (vehicle). The main goal is to measure redness reduction 15 minutes and 10 hours after the first dose.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OCULAR HYPEREMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Contact Alcon Call Center for Trial Locations
Fort Worth, Texas, 76134, United States